Plasmacytoid Dendritic Cell, Slan(+)-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients

SIMPLE SUMMARY: The advent of therapy with immune checkpoint inhibitors (ICIs) has determined a significant survival benefit in patients with non-small cell lung cancer (NSCLC). However, 50–80% of patients do not respond to ICI monotherapy. Therefore, the identification of biomarkers for predicting...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettinella, Francesca, Lattanzi, Chiara, Donini, Marta, Caveggion, Elena, Marini, Olivia, Iannoto, Giulia, Costa, Sara, Zenaro, Elena, Fortunato, Tiago Moderno, Gasperini, Sara, Giani, Matteo, Belluomini, Lorenzo, Sposito, Marco, Insolda, Jessica, Scaglione, Ilaria Mariangela, Milella, Michele, Adamo, Annalisa, Poffe, Ornella, Bronte, Vincenzo, Dusi, Stefano, Cassatella, Marco A., Ugel, Stefano, Pilotto, Sara, Scapini, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647811/
https://www.ncbi.nlm.nih.gov/pubmed/37958458
http://dx.doi.org/10.3390/cancers15215285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647811/
https://www.ncbi.nlm.nih.gov/pubmed/37958458
http://dx.doi.org/10.3390/cancers15215285

Ejemplares similares